Position in AVXL
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$782
-$439 QoQ
Shares Held
302
-24.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#164
of 179 holders
Holding Since
Mar 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Derivatives in AVXL
reported options exposure · as of Jun 30, 2026CallValue
$125,097
CallShares
48,300
PutValue
$1,554
PutShares
600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. AVXL ranks #121 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in AVXL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,554 | 600 | Put | Sole | 2026-08-03 | |
| 2026-06-30 | $125,097 | 48,300 | Call | Sole | 2026-08-03 | |
| 2026-06-30 | $782 | 302 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $77,671 | 25,300 | Put | Sole | 2026-05-13 | |
| 2026-03-31 | $124,642 | 40,600 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $1,221 | 398 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $21,392 | 6,009 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $71,200 | 20,000 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $124,600 | 35,000 | Call | Sole | 2026-02-13 | |
| 2025-03-31 | $202,488 | 23,600 | Put | Sole | 2025-05-14 | |
| 2025-03-31 | $97,812 | 11,400 | Call | Sole | 2025-05-14 | |
| 2024-12-31 | $108,474 | 10,100 | Put | Sole | 2025-02-13 | |
| 2024-12-31 | $343,680 | 32,000 | Call | Sole | 2025-02-13 | |
| 2024-06-30 | $320,298 | 75,900 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $98,748 | 23,400 | Put | Sole | 2024-08-14 | |
| 2024-03-31 | $410,763 | 80,700 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $132,849 | 26,100 | Put | Sole | 2024-05-15 | |
| 2023-12-31 | $198,303 | 21,300 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $107,065 | 11,500 | Call | Sole | 2024-02-14 | |
| 2023-06-30 | $77,235 | 9,500 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $12,195 | 1,500 | Put | Sole | 2023-08-14 | |
| 2023-03-31 | $253,672 | 29,600 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $21,425 | 2,500 | Put | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||